Contineum Therapeutics, Inc (NASDAQ:CTNM) IPO will take place April, 05 on the NASDAQ exchange under the ticker CTNM.
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on October 02, 2024.
See also: Benzinga IPO Calendar
About Contineum Therapeutics, Inc
Contineum Therapeutics, Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of NI&I indications with high unmet need.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
